Navratil H - Search Results

1

A multicenter, double-blind, placebo-controlled trial of the efficacy of prazosin in the treatment of dysuria associated with benign prostatic hypertrophy.

Le Duc A, Cariou G, Baron C, Cukier J, Quentel P, Faure G, Rambeaud JJ, Navratil H, Costa P, Richaud JJ, et al. Le Duc A, et al. Among authors: navratil h. Urol Int. 1990;45 Suppl 1:56-62. doi: 10.1159/000282031. Urol Int. 1990. PMID: 1690483 Clinical Trial.

2

[Therapeutic indications and complementary explorations in benign prostatic hypertrophy: significance of simultaneous recordings].

Costa P, Mottet N, Louis JF, Navratil H. Costa P, et al. Among authors: navratil h. Prog Urol. 1992 Jun;2(3):506-16. Prog Urol. 1992. PMID: 1284552 Review. French.

3

Quantitative topographic distribution of epithelial and mesenchymal components in benign prostatic hypertrophy.

Costa P, Robert M, Sarrazin B, Mottet N, Navratil H. Costa P, et al. Among authors: navratil h. Eur Urol. 1993;24(1):120-3. doi: 10.1159/000474278. Eur Urol. 1993. PMID: 7689969

4

Percentage area density of epithelial and mesenchymal components in benign prostatic hyperplasia: comparison of results between single biopsy, multiple biopsies and multiple tissue specimens.

Robert M, Costa P, Bressolle F, Mottet N, Navratil H. Robert M, et al. Among authors: navratil h. Br J Urol. 1995 Mar;75(3):317-24. doi: 10.1111/j.1464-410x.1995.tb07342.x. Br J Urol. 1995. PMID: 7537601

5

Prevention of the transient adverse effects of a gonadotropin-releasing hormone analogue (buserelin) in metastatic prostatic carcinoma by administration of an antiandrogen (nilutamide).

Kuhn JM, Billebaud T, Navratil H, Moulonguet A, Fiet J, Grise P, Louis JF, Costa P, Husson JM, Dahan R, et al. Kuhn JM, et al. Among authors: navratil h. N Engl J Med. 1989 Aug 17;321(7):413-8. doi: 10.1056/NEJM198908173210701. N Engl J Med. 1989. PMID: 2503723 Clinical Trial.

6

Carboplatin and urothelial tumors.

Mottet-Auselo N, Bons-Rosset F, Costa P, Louis JF, Navratil H. Mottet-Auselo N, et al. Among authors: navratil h. Oncology. 1993 Nov;50 Suppl 2:28-36. doi: 10.1159/000227258. Oncology. 1993. PMID: 8233299 Review.

7

[Effectiveness of and tolerance to intracavernous injection of moxisylyte in patients with erectile dysfunction: effect/dose relationship versus placebo].

Navratil H, Costa P, Louis JF, Andro MC, Saur P. Navratil H, et al. Prog Urol. 1995 Nov;5(5):690-6. Prog Urol. 1995. PMID: 8580980 Clinical Trial. French.

8

Intermittent versus continuous hormone deprivation in metastatic prostate cancer: preliminary data from an ongoing European study.

Mottet N, Costa P, Navratil H. Mottet N, et al. Among authors: navratil h. Prostate Cancer Prostatic Dis. 1999 Nov;2(S2):S2-S4. doi: 10.1038/sj.pcan.4500317. Prostate Cancer Prostatic Dis. 1999. PMID: 12496828 No abstract available.

9

Transrectal ultrasonography in prostatic cancer: interexaminer variability of interpretation.

Mottet N, Lehmann M, Cicorelli S, Dagues F, Louis JF, Costa P, Daures JP, Navratil H. Mottet N, et al. Among authors: navratil h. Eur Urol. 1997;32(2):150-4. Eur Urol. 1997. PMID: 9286644

10

Disposition of roxithromycin in the epididymis after repeated oral administration.

Costa P, Desclaux d'Arramon F, Gouby A, Navratil H, Geny F, Galtier M, Bressolle F. Costa P, et al. Among authors: navratil h. J Antimicrob Chemother. 1992 Aug;30(2):197-201. doi: 10.1093/jac/30.2.197. J Antimicrob Chemother. 1992. PMID: 1399928

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

101 results

Search Page

Filters